Log in to save to my catalogue

Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tum...

Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tum...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0e968c6faaeb4f6fba81a48f2e2d888b

Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

About this item

Full title

Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

Publisher

Egypt: Hindawi

Journal title

Journal of immunology research, 2022-06, Vol.2022, p.1-13

Language

English

Formats

Publication information

Publisher

Egypt: Hindawi

More information

Scope and Contents

Contents

Objective. To analyze the therapeutic effects and organ rejection of anti-PD-1 immunotherapy or antivascular targeting therapy on patients with combined malignancies after organ transplantation. Methods. We collected retrospective studies on “post-transplantation, cancer, immunotherapy, and vascular targeting therapy” in Embase, Wanfang database, C...

Alternative Titles

Full title

Immunotherapy and Antivascular Targeted Therapy in Patients’ Treatment with Concurrent Malignant Tumors after Organ Transplantation: Opportunity or Challenge

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0e968c6faaeb4f6fba81a48f2e2d888b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0e968c6faaeb4f6fba81a48f2e2d888b

Other Identifiers

ISSN

2314-8861

E-ISSN

2314-7156

DOI

10.1155/2022/6440419

How to access this item